English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Synthesis of High Affinity Contrast Agents for Targeted MR Neuroimaging

Gündüz, S., Power, A., Logothetis, N. K., & Angelovski, G. (2013). Synthesis of High Affinity Contrast Agents for Targeted MR Neuroimaging. Poster presented at COST TD1004 Action: Theranostics Imaging and Therapy: An Action to Develop Novel Nanosized Systems for Imaging: Guided Drug Delivery, Athens, Greece.

Item is

Basic

show hide
Item Permalink: http://hdl.handle.net/21.11116/0000-0000-FE75-F Version Permalink: http://hdl.handle.net/21.11116/0000-0001-51A9-5
Genre: Poster

Files

show Files

Creators

show
hide
 Creators:
Gündüz, Serhat1, 2, Author              
Power, AT1, 2, Author              
Logothetis, Nikos K1, 2, Author              
Angelovski, Goran1, 2, Author              
Affiliations:
1Max Planck Institute for Biological Cybernetics, Max Planck Society, ou_1497794              
2Department Physiology of Cognitive Processes, Max Planck Institute for Biological Cybernetics, Max Planck Society, ou_1497798              

Content

show
hide
Free keywords: -
 Abstract: Magnetic resonance imaging (MRI) has become one of the essential noninvasive diagnostic techniques for soft tissues and diseases. Contrast agents have been developed to produce additional contrast and increase the signal intensity for MRI [1]. Here we report on the synthesis development of target specific contrast agents for MR neuroimaging. Monomeric and dendrimeric targeted contrast agents (TCA) were synthesized taking advantage of the highly specific interaction of the protein avidin with its ligand biotin [2]. The classical monomeric CAs have disadvantages such as non-specificity, fast renal excretion, low contrast efficiency and therefore they require a high dosage. To overcome this problem, we use multivalent, highly-branched dendrimeric molecules that are capable of carrying large number of CAs and hence the MRI amplification [3]. The TCAs are additionally labeled with a fluorescent dye, for to achieve their multimodal detection by means of optical and MR-based techniques. Upon their preparation, the biotinylated TCAs are suitable for labeling genetically engineered cell surface receptors that contain avidin. [4]. The preliminary experiments showed that TCAs bind specifically to avidin-coated beads (Figure 1). Their further characterization ensures exciting progress in neuroimaging enabling high resolution MRI of specific neuronal populations.

Details

show
hide
Language(s):
 Dates: 2013-09
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Method: -
 Identifiers: -
 Degree: -

Event

show
hide
Title: COST TD1004 Action: Theranostics Imaging and Therapy: An Action to Develop Novel Nanosized Systems for Imaging: Guided Drug Delivery
Place of Event: Athens, Greece
Start-/End Date: -

Legal Case

show

Project information

show

Source 1

show
hide
Title: COST TD1004 Action: Theranostics Imaging and Therapy: An Action to Develop Novel Nanosized Systems for Imaging: Guided Drug Delivery
Source Genre: Proceedings
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: - Sequence Number: P21 Start / End Page: 71 Identifier: -